KALYRA PHARMACEUTICALS, INC.

Profile

Company Names

KALYRA PHARMACEUTICALS, INC.

Addresses

6181 CORNERSTONE COURT, SUITE 105-106, SAN DIEGO, CA 92121

8881 DETWILER ROAD, ESCONDIDO, CA 92029

Phone Numbers

(858) 901-1942

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2012

State Incorporated:

CALIFORNIA

Total Amount Raised:

$6,181,380.00

Number of Funding Rounds:

1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2013-08-14 
$6,181,380.00 
$7,000,000.00 
$818,620.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
MICHAEL 
E. 
BREEDE 
DIRECTOR
KALYRA PHARMACEUTICALS, INC.
KEVIN 
D. 
BUNKER 
EXECUTIVE OFFICER, DIRECTOR
KALYRA PHARMACEUTICALS, INC.
CAM 
 
GALLAGHER 
EXECUTIVE OFFICER
NERVEDA INC   |  NERVEDA LLC   |  SORRENTO THERAPEUTICS, INC.   |  KALYRA PHARMACEUTICALS, INC.   |  SG PHARMACEUTICALS, INC.   |  RETROSENSE THERAPEUTICS, LLC   |  ZAVANTE THERAPEUTICS, INC.   |  ZENO PHARMACEUTICALS, INC.   |  ONCTERNAL THERAPEUTICS, INC.   |  VELOSBIO INC.   |  OCUPHIRE PHARMA, INC.   |  OCUPHIRE PHARMA, INC.   |  SELECTION, INC.   |  OPUS GENETICS, INC.   |  ALESSA THERAPEUTICS, INC.
CAM 
L. 
GARNER 
DIRECTOR
ZOGENIX INC   |  MERITAGE PHARMA INC   |  ELEVATION PHARMACEUTICALS INC   |  NEURELIS, INC.   |  EVOKE PHARMA INC   |  KALYRA PHARMACEUTICALS, INC.   |  ORPRO THERAPEUTICS, INC.   |  TOKALAS, INC.   |  ALASTIN SKINCARE, INC.   |  ZAVANTE THERAPEUTICS, INC.   |  ADIGICA HEALTH, INC.   |  ONCTERNAL THERAPEUTICS, INC.
SCOTT 
L. 
GLENN 
DIRECTOR
EVOKE PHARMA INC   |  EXAGEN DIAGNOSTICS INC   |  SELEXAGEN THERAPEUTICS, INC.   |  KALYRA PHARMACEUTICALS, INC.   |  TOKALAS, INC.   |  ALASTIN SKINCARE, INC.   |  ONCTERNAL THERAPEUTICS, INC.   |  PRECISION IBD, INC.   |  VELOSBIO INC.   |  REBALANCE HEALTH, INC.
NED 
A. 
ISRAELSEN 
EXECUTIVE OFFICER, DIRECTOR
KALYRA PHARMACEUTICALS, INC.
DIRK 
A. 
THYE 
DIRECTOR
KALYRA PHARMACEUTICALS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2013-11-08
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-08-14 
2013-08-21
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-08-14 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#